Inertia For Supply Chain Change May Stick Even If BIOSECURE Fails

 
• By Sarah Karlin-Smith
  
close up of Asia on world map
Pharma supply chains may continue diversifying their supply chains even without the BIOSECURE legislation. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Distribution/Supply Chain

More from Geography